Presentations from the Frontiers in Oncologic Prostate Care and Ablative Local Therapy

SESSION 1: PROSTATE IMAGING, SAMPLING AND SPACING

WELCOME

Arvin K. George, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

PIRADS V2.1 – What a Urologist Needs to Know?

Sadhna Verma, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

Can Imaging Replace Prostate Biopsy – Primary Detection, Active Surveillance and Recurrent PCa?

Veeru Kasivisvanathan, MBBS, BSc, FRCS, PhD, MSc, PGCert, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

Discussion 1

Arvin K. George, MD, Sadhna Verma,MD, MBA, FSAR, Veeru Kasivisvanathan, MBBS, BSc, FRCS, PhD, MSc, PGCert, and have a discussion during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

PET Scanning in Primary Detection of Prostate Cancer

Steven Rowe, MD, PhD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

PSMA PET for Preoperative Planning of Prostate Cancer: Nodes, Nerves and Margins

James Wysock, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

Discussion 2

Steven Rowe, MD, James Wysock, MD, and Abhinav Sidana, MD, presented this discussion during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

Transperineal vs Transrectal Biopsy Clinical Trials: Mo’ Data Mo’ Problems

Arvin K. George, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

Point Counterpoint: Risk Stratification for Biopsy: MRI

Peter A. Pinto, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

Point Counterpoint: Risk Stratification for Biopsy: Biomarkers

Juan Javier-DesLoges, MD, MS, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

Rectal Spacer

Abhinav Sidana, MD, MPH, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

SESSION 2: ARTIFICIAL INTELLIGENCE

Introduction to AI in Healthcare

Giovanni Cacciamani, MD, MSc, FEBU, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

AI and Prostate Imaging and Biopsy

Baris Turkbey, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

AI and Treatment Planning for Prostate Cancer

Andre Abreu, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

Optimizing Flow: Practical AI Applications in Urology

Arun Rai, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

Panel Discussion: Artificial Intelligence in Prostate Cancer

Giovanni Cacciamani, MD, MSc, FEBU, moderators this panel during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

ADVANCED PROSTATE CANCER MASTERCLASS

Course Introduction: Description of Terminology and Review of Guidelines

Natalie Reizine, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

Genetic Testing in Prostate Cancer Management

Abhinav Sidana, MD, MPH, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

Optimal Management of Biochemically Recurrent Nonmetastatic Prostate Cancer

Aaron Berger, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

Discussion

Natalie Reizine, MD, and Alan Tan, MD, had a discussion during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

Metastatic Castrate Sensitive Prostate Cancer

Rana McKay, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

Oligometastatic Prostate Cancer

Daniel Song, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

Panel Discussion: Local Prostate Therapy for Metastatic Prostate Cancer

Natalie Reizine, MD, moderators this panel discussion during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

Urologist Led Advanced Prostate Cancer Practice Tips, Tricks and Pitfalls

Aaron Berger, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

The Role of PARP Inhibition and Immunotherapy in CRPC

Alan Tan, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

Challenging Cases: Prostate Cancer

Natalie Reizine, MD, and Alan Tan, MD, presented this cases during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

Radiopharmaceuticals in Advanced Prostate Cancer

Steven Rowe, MD, PhD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 17, 2024.

HANDS-ON COURSE I • STATE-OF-THE-ART BPH MANAGEMENT

Welcome & Introduction: STATE-OF-THE-ART BPH MANAGEMENT

John Michael DiBianco, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 18, 2024.

Surgical BPH: 2024 Updates and Where Are We Going

Nicole Miller, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 18, 2024.

Office BPH: 2024: Updates and Where Are We Going

Kevin Zorn, MD, FRCSC, FACS, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 18, 2024.

Elevated PSA and Obstructive LUTS

Bilal Chughtai, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 18, 2024.

Management of Obstructive LUTS in Men with Prostate Cancer

Kevin Zorn, MD, FRCSC, FACS, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 18, 2024.

Prostate Cancer after BPH Treatment

John Michael DiBianco, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 18, 2024.

UroLift: Is There a Role?

Amin Herati, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 18, 2024.

Is There a Role for Temporary Urethral Stents?

Karla Witzke, DO, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 18, 2024.

What is the Role of HoLEP?

Nicole Miller, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 18, 2024.

Panel Discussion

John Michael DiBianco, MD, moderators this panel discussion during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 18, 2024.

Aquablation: How I Do It Now?

Kevin Zorn, MD, FRCSC, FACS, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 18, 2024.

Optilume for BPH

Bilal Chughtai, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 18, 2024.

HoLEP: How I Did It and How I Do It Now?

Nicole Miller, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 18, 2024.

Panel Discussion

John Michael DiBianco, MD, moderators this panel discussion during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 18, 2024.

SESSION 3: INTRODUCTION TO FOCAL THERAPY

The Changing Landscape of Focal Therapy for Prostate Cancer

Herbert Lepor, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 18, 2024.

Patient Selection: How to Pick a Focal Therapy Candidate

Derek Lomas, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 18, 2024.

Discussion

Arvin K. George, MD, moderators this discussion during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 18, 2024.

Energy Selection: Ablative Technologies for Focal Therapy

Andre Abreu, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 18, 2024.

Point Counterpoint: Is Focal Therapy Ready for Prime Time? (Yes)

Ruben Olivares, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 18, 2024.

Point Counterpoint: Is Focal Therapy Ready for Prime Time? (No)

Michael Rothberg, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 18, 2024.

Panel Discussion: Patient and Treatment Selection

Abhinav Sidana, MD, MPH, moderators this panel during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 18, 2024.

SESSION 4: OUTCOMES AND SURVEILLANCE OF FOCAL THERAPY

Outcomes of Recent Clinical Trials for Focal Therapy

Derek Lomas, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 18, 2024.

Optimal Surveillance Algorithm Following Focal Therapy of Prostate Cancer

Herbert Lepor, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 18, 2024.

Interpretation of Post Focal Therapy Imaging: Target and Pifab

Sadhna Verma, MD, MBA, FSAR, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 18, 2024.

Discussion

Abhinav Sidana, MD, MPH, moderators this panel during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 18, 2024.

SESSION 5: FOCAL THERAPY CHALLENGES AND CASE DISCUSSIONS

Results of the PRIME Trial: Biparametric Versus Multiparametric MRI for Prostate Cancer
Detection – Implications for Focal Therapy

Veeru Kasivisvanathan, MBBS, BSc, FRCS, PhD, MSc, PGCert
BSc, FRCS, PhD, MSc, PGCert, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 19, 2024.

Complications of Focal Therapy – Risk Factors, Timepoints, and Management

Amir Lebastchi, MD, moderators this panel during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 19, 2024.

Complications of Focal Therapy – Risk Factors, Timepoints, and Management

Amir Lebastchi, MD, moderators this panel during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 19, 2024.

Mechanisms and Management of Recurrences

Abhinav Sidana, MD, MPH, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 19, 2024.

Case Discussion: Challenging Cases in Focal Therapy

Arvin K. George, MD, moderators this panel discussions during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 19, 2024.

KEYNOTE LECTURE • Introduction of Disruptive Technologies: The Lessons From the
Minimally Invasive Surgery

Ralph Clayman, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 19, 2024.

Oncological and Functional Outcomes Post Focal Low-Dose-Rate Brachytherapy for Low-Intermediate Risk Prostate Cancer – Results from Australia’s LIBERATE Registry

Mohammadmehdi Adhami, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 19, 2024.

Spatial Characterization and AI-Driven Prevention of Residual Cancer Following Focal Therapy

Preston Sprenkle, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 19, 2024.

Best Clinical Practices for Transperineal Prostate Biopsy: Results from an International Delphi Consensus

Lorenzo Ramacciotti, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 19, 2024.

SV Recurrences After Radiation: Is Ablation Feasible and Safe?

Aaron Katz, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 19, 2024.

SESSION 6: CONTROVERSIES IN PROSTATE CANCER

Diet and Prostate Cancer: What We Need to Know to Tell our Patients?

Stacy Loeb, MD, MSc, PhD (Hon) (Hon), MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 19, 2024.

Role of Whole Gland Ablation in Prostate Cancer

James Wysock, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 19, 2024.

Starting a Transperineal Prostate Biopsy Program: Cost Effective Strategy for Implementation

Richard Wu, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 19, 2024.

CAPTAIN: A Randomized Controlled Trial of MRI-Guided Transurethral Ultrasound Ablation
of the Prostate versus Radical Prostatectomy

Xiaosong Meng, MD, PhD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on October 19, 2024.